Clinical trial

Effect of Astaxanthin on the Patients With Alzheimer Disease

NCT05015374

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-11-14

PhaseNA

Study timeline

Study start (actual)2018-11-14Date precision: day

Registry last updated2024-09-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Diseaseunresolved

Interventions

AstaxanthinDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Kaohsiung Medical University Chung-Ho Memorial Hospitallead sponsor

China Medical University, Chinacollaborator

Mapped research locations

Kaohsiung CityTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05015374 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.